In the news
Cost-benefit analysis set for Advate, hemophilia A treatment
December 21, 2020Hemophilia News Today
Related news
In the news
September 19, 2023
Prime Therapeutics taps Inovalon to enhance specialty pharmacy through cloud-based tech
Fierce Healthcare
In the news
September 14, 2023
Mostafa Kamal Talks Prime Therapeutics, Magellan Rx Integration, the Organizations Trajectory, More
Managed Healthcare Executive
In the news
September 7, 2023
Ben Urick of Prime Therapeutics Talks How Medication Adherence Leads to Cost Savings | 2023 PBMI Annual National Conference
Managed Healthcare Executive